Advertisement

Neuropeptide Y and the cerebral circulation

  • Lars Edvinsson
Part of the Experientia Supplementum book series (EXS, volume 95)

Concluding remarks

The presence of NPY receptors on both endothelial and vascular smooth muscle cells indicates that blood-borne NPY as well as NPY stemming from surrounding nerves can affect contractile responses of cerebral vessels. In addition, endothelial cells may themselves be a source of NPY as well as a site of NPY metabolism. Understanding the roles of NPY in cerebrovascular regulation is complicated by multiple receptor subtypes, signalling pathways and cellular responses. Vasodilatory effects and vascular remodeling actions underscore the fact that NPY cannot just be classified as a potent vasoconstrictor. NPY is an important sympathetic transmitter, but it clearly acts via intracerebral nerves as well to regulate local CBF.

Keywords

Cerebral Blood Flow Middle Cerebral Artery Occlusion Cerebral Vasospasm Cerebral Circulation Cereb Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R (1983) Neuropeptide Y: Cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett 43: 79–84CrossRefPubMedGoogle Scholar
  2. 2.
    Edvinsson L, Copeland J, Emson PC, McCulloch J, Uddman R (1987) Nerve fibres containing neuropeptide Y in the cerebrovascular bed: Immunocytochemistry, radioimmunoassay and vasomotor effects. J Cereb Blood Flow Metab 7: 45–57PubMedGoogle Scholar
  3. 3.
    Cunha e Sá M, Pinto Barroso C, Castro Caldas M, Edvinsson, L, Gulbenkian S (1997) Innervation pattern of malformative cortical vessels in Sturge-Weber disease: A histochemical, immunohistochemical and ultrastructural study. Neurosurgery 41: 872–877Google Scholar
  4. 4.
    Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143–150PubMedGoogle Scholar
  5. 5.
    Franco-Cereceda A, Liska J (1998) Neuropeptide Y Y1 receptors in vascular pharmacology. Eur J Pharmacol 349: 1–14CrossRefPubMedGoogle Scholar
  6. 6.
    Abounader R, Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Quirion R, Hamel E (1999) Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture. J Cereb Blood Flow Metab 19: 155–163PubMedGoogle Scholar
  7. 7.
    Nilsson T, Cantera L, Edvinsson L (1996) Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries. Neurosci Lett 204: 145–148CrossRefPubMedGoogle Scholar
  8. 8.
    Bao L, Kopp J, Zhang X, Xu ZQ, Zhang LF, Wong H, Walsh J, Hökfelt T (1997) Localization of neuropeptide Y Y1 receptors in cerebral blood vessels. Proc Natl Acad Sci USA 94: 12661–12666PubMedGoogle Scholar
  9. 9.
    Abounader R, Villemure JG, Hamel E (1995) Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226. Br J Pharmacol 116: 2245–2250PubMedGoogle Scholar
  10. 10.
    Dacey RG, Bassett JE and Takayasu M (1988) Vasomotor responses of rat intracerebral arterioles to vasoactive intestinal peptide, substance P, neuropeptide Y, and bradykinin. J Cereb Blood Flow Metab 8: 254–261PubMedGoogle Scholar
  11. 11.
    Edvinsson L (1985) Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries. Acta Physiol Scand 125: 33–41PubMedGoogle Scholar
  12. 12.
    Edvinsson L, McCulloch J, Uddman R (1982) Feline cerebral veins and arteries: Comparison of autonomic innervation and vasomotor responses. J Physiol 325: 161–173PubMedGoogle Scholar
  13. 13.
    Fallgren B, Arlock P, Jansen I, Edvinsson L (1990) Neuropeptide Y in cerebrovascular function: Comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in the guinea pig basilar artery. Neurosci Lett 114: 117–122CrossRefPubMedGoogle Scholar
  14. 14.
    Tanaka Y, Nakazawa T, Ishiro H, Saito M, Uneyama H, Iwata S, Ishii K, Nakayama K (1995) Ca2+ handling mechanisms underlying neuropeptide Y-induced contraction in canine basilar artery. Eur J Pharmacol 289: 59–66PubMedGoogle Scholar
  15. 15.
    Fredholm BB, Jansen I, Edvinsson L (1985) Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand 124: 467–469PubMedGoogle Scholar
  16. 16.
    Nilsson T, You J, Sun X, Hedner T, Edvinsson L (1996) Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. Blood Pressure 5: 164–169PubMedGoogle Scholar
  17. 17.
    You J, Edvinsson L, Bryan RM Jr, (2001) Neuropeptide Y (NPY)-mediated constriction and dilation in rat middle cerebral arteries. J Cereb Blood Flow Metab 21: 77–84PubMedGoogle Scholar
  18. 18.
    Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Yamawaki T, Takeda H, Matsuoka S (1993) Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide. Brain Res Bull 31: 443–448CrossRefPubMedGoogle Scholar
  19. 19.
    You J, Zhang W, Jansen-Olesen I, Edvinsson L (1995) Relation between cyclic GMP generation and cerebrovascular reactivity; modulation by NPY and alpha-trinositol. Pharmacol Toxicol 77: 48–56PubMedGoogle Scholar
  20. 20.
    Abounader R, Hamel E (1997) Associations between neuropeptide Y nerve terminals and intraparenchymal microvessels in rat and human cerebral cortex. J Comp Neurol 388: 444–453CrossRefPubMedGoogle Scholar
  21. 21.
    Allen JM, Schon F, Todd N, Yeats JC, Crockard HA, Bloom SR (1984) Presence of neuropeptide Y in human circle of Willis and its possible role in cerebral vasospasm. Lancet 2: 550–552PubMedGoogle Scholar
  22. 22.
    Tuor U, Edvinsson L, McCulloch J (1985) Neuropeptide Y and cerebral blood flow. Lancet 1: 1271PubMedGoogle Scholar
  23. 23.
    Suzuki Y, Shibuya M, Ikegaki I, Satoh S, Takayasu M, Asano T (1988) Effects of neuropeptide Y on canine cerebral circulation. Eur J Pharmacol 146: 271–277CrossRefPubMedGoogle Scholar
  24. 24.
    Tuor U, Kelly PAT, Edvinsson L, McCulloch J (1990) Neuropeptide Y and the cerebral circulation. J Cereb Blood Flow Metab 10: 591–601PubMedGoogle Scholar
  25. 25.
    Tuor U, Kelly PAT, Edvinsson L, Tatemoto K, McCulloch J (1985) Neuropeptide Y and the regulation of local cerebral blood flow: A quantitative autoradiographic study. J Cereb Blood Flow Metab 5: S513–S514Google Scholar
  26. 26.
    Goadsby PJ, Edvinsson L (1993) Examination of the involvement of neuropeptide Y (NPY) in cerebral autoregulation using the novel NPY antagonist PP56. Neuropeptides 24: 27–33CrossRefPubMedGoogle Scholar
  27. 27.
    Vraamark T, Waldemar G, Edvinsson L, Paulson OB (1997) Differential effects of increasing doses of alpha-trinositol on cerebral autoregulation. Pharmacol Toxicol 80: 38–43PubMedGoogle Scholar
  28. 28.
    Abel W, Han C, Noe BD, McDonald JK (1988) Neuropeptide Y: Vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res 463: 250–258CrossRefPubMedGoogle Scholar
  29. 29.
    Jackowski A, Crockard A, Burnstock G, Lincoln J (1989) Alterations in serotonin and neuropeptide content of cerebrovascular sympathetic nerves following experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 9: 271–279PubMedGoogle Scholar
  30. 30.
    Juul R, Edvinsson L, Fredriksen TA, Ekman R, Brubakl AO, Gisvold SE (1990) Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man; involvement of sympathetic neuropeptide Y in cerebral vasospasm. Acta Neurochir (Wien) 107: 75–81CrossRefGoogle Scholar
  31. 31.
    Suzuki Y, Sato S, Suzuki H, Namba J, Ohtake R, Hashigami Y, Suga S et al. (1989) Increased neuropeptide Y concentrations in cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 20: 1680–1684PubMedGoogle Scholar
  32. 32.
    Chen SH, Cheung RT (2002) Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume. Brain Res 15:927: 138–143Google Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2006

Authors and Affiliations

  • Lars Edvinsson
    • 1
  1. 1.Division of Experimental Vascular Research, Department of Internal MedicineLund University HospitalLundSweden

Personalised recommendations